PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 99 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2014. The put-call ratio across all filers is 3.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $72,000 | +414.3% | 160,687 | +1066.5% | 0.00% | – |
| Q1 2016 | $14,000 | -87.9% | 13,775 | -65.1% | 0.00% | – |
| Q4 2015 | $116,000 | +157.8% | 39,472 | +177.6% | 0.00% | – |
| Q3 2015 | $45,000 | -97.2% | 14,217 | -94.7% | 0.00% | -100.0% |
| Q2 2015 | $1,581,000 | +131.8% | 267,089 | +318.6% | 0.00% | +100.0% |
| Q1 2015 | $682,000 | -34.9% | 63,811 | -42.8% | 0.00% | 0.0% |
| Q4 2014 | $1,047,000 | +179.9% | 111,489 | +128.8% | 0.00% | – |
| Q3 2014 | $374,000 | +59.8% | 48,737 | +86.6% | 0.00% | – |
| Q2 2014 | $234,000 | +188.9% | 26,115 | +70.7% | 0.00% | – |
| Q1 2014 | $81,000 | +200.0% | 15,295 | +41.3% | 0.00% | – |
| Q4 2013 | $27,000 | -30.8% | 10,824 | -24.2% | 0.00% | – |
| Q3 2013 | $39,000 | -60.2% | 14,277 | -28.1% | 0.00% | – |
| Q1 2013 | $98,000 | – | 19,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|